IA Trial Radar | ||
|---|---|---|
El ensayo clínico NCT07006142 para Upper Endoscopy, GLP1-R-related Disease está reclutando. Consulte la vista de tarjeta del Radar de Ensayos Clínicos y las herramientas de descubrimiento de IA para conocer todos los detalles. O haga cualquier pregunta aquí. | ||
Un estudio coincide con los criterios de filtro
Vista de tarjeta
Volver a la búsqueda
Clínica MayoEffect of Prolonged Fasting Time on Gastric Residual Volume in Patients Taking GLP1 Receptor Agonists 150
Los detalles del ensayo clínico están disponibles principalmente en inglés. ¡Sin embargo, IA Trial Radar puede ayudar! Simplemente haga clic en 'Explicar el estudio' para ver y discutir la información del estudio en el idioma que haya seleccionado.
El ensayo clínico NCT07006142 es un estudio intervencionista para Upper Endoscopy, GLP1-R-related Disease. Su estado actual es: reclutando. El estudio se inició el 1 de agosto de 2025, con el objetivo de reclutar a 150 participantes. Dirigido por la Clínica Mayo, se espera que finalice el 30 de abril de 2026. Los datos se actualizaron por última vez en ClinicalTrials.gov el 3 de febrero de 2026.
Resumen
The aim of this study is to determine whether a modified fasting protocol can reduce the potential risk of aspiration for patients currently prescribed GLP1-RAs.
Descripción detallada
The overall objective of this project is to identify a reasonable means by which patients on GLP1-RAs can be safely cared for in the perioperative period that can be agreed upon by all groups involved in perioperative patient care. This will be assessed in patients undergoing upper endoscopy specifically since assessment of gastric contents would be minimally invasive for this patient population receiving anesthetic ...Mostrar más
Título oficial
Effect of Prolonged Fasting Time on Gastric Residual Volume in Patients Taking GLP1 Receptor Agonists
Condiciones médicas
Upper EndoscopyGLP1-R-related DiseaseOtros ID del estudio
- 23-013192
Número del NCT
Inicio del estudio (real)
2025-08-01
Última actualización
2026-02-03
Fecha de finalización (estimada)
2026-04-30
Inscripción (prevista)
150
Tipo de estudio
Intervencionista
FASE
N/A
Estado general
Reclutando
Palabras clave
GLP1 receptor agonists
upper endoscopy
upper endoscopy
Objetivo principal
Prevención
Método de asignación
N/A
Modelo de intervención
Grupo único
Enmascaramiento
Simple ciego
Brazos / Intervenciones
| Grupo de participantes | Intervención/Tratamiento |
|---|---|
Sin intervenciónNormal fasting guidelines and not taking GLP1-RAs Patients who are not taking GLP1 RAs (Receptor Agonists) and who will abide by the normal fasting guidelines | N/A |
Sin intervenciónNormal fasting guidelines with GLP1-RAs Patients who are taking GLP1 RAs (Receptor Agonists) for either diabetes or weight loss management who will abide by normal fasting guidelines | N/A |
ExperimentalModified fasting guidelines with GLP1-RAs Patients who are prescribed and taking GLP1 RAs (Receptor Agonists) for either diabetes or weight loss management who follow the modified fasting guidelines. Modified fasting consists of a full-liquid diet 48 hours prior to the procedures, clear liquid diet 24 hours prior to their procedure, and nothing by mouth (NPO) after midnight on the day of their procedure. | Modified Fasting Guidelines Patients will follow a full-liquid diet 48 hours prior to their procedure, clear liquid diet 24 hours prior to their procedure, and nothing by mouth (NPO) after midnight on the day of their procedure |
Resultado primario
Resultado secundario
| Medida de resultado | Descripción de la medida | Periodo de tiempo |
|---|---|---|
Gastric contents | Number of patients who were found to have gastric contents within the stomach during the upper endoscopy. | Baseline |
| Medida de resultado | Descripción de la medida | Periodo de tiempo |
|---|---|---|
Diagnosis of aspiration within 72 hours of procedure | Whether or not a patient was diagnosed with aspiration will be determined via chart review for 72 hours after the completion of upper endoscopy. A note documenting aspiration or an ICD code associated with aspiration will indicate that this outcome occurred. | From the time of upper endoscopy until 72 hours post-procedure. |
Aspiration pneumonitis diagnosis postoperatively | The number of patients who have a diagnosis of aspiration pneumonitis, as identified by the presence of ICD codes J69.0 or J69.8, postoperatively. | 72 hours after completion of upper endoscopy |
Postprocedural ICU admission | The number of patients who were admitted to the ICU immediately after upper endoscopy. | Immediately after upper endoscopy |
Asistente de participación
Criterios de elegibilidad
Criterios de edad
Adulto, Adulto mayor
Edad mínima
18 Years
Criterios de sexo
Todos
- Patients undergoing elective upper endoscopy with gastroenterology team
- Urgent or emergent procedure
- Inclusion of colonoscopy or antegrade small bowel enteroscopy in planned procedure
- Upper GI barium study performed in past 24 hours.
- Gastroparesis
- Achalasia
- Pancreatitis
- Use of outpatient pro-motility medications
- Patient refusal
- Inability for patient to provide own consent
Clínica Mayo861 estudios activos para explorarParte responsable del estudio
Krishnan Ramanujan, Investigador principal, Principal Investigator, Mayo Clinic
Contactos centrales del estudio
Contacto: Krishnan Ramanujan, MD, 507-422-4898, [email protected]
1 Centros del estudio en 1 países
Minnesota
Mayo Clinic in Rochester, Rochester, Minnesota, 55905, United States
Krishnan Ramanujan, MD, Contacto, 507-422-4898, [email protected]
Reclutando